You are here

Lipids & Metabolic

 

Soda taxes have recently been implemented by several U.S. cities as a way to generate revenue while curbing sugary beverage consumption, a driver of the nation’s obesity epidemic. But it turns out Americans were already reaching for a bottle of ‘pop’ less often.

'Tis the season for sampling pumpkin pies and gorging on turkey leftovers, but diners might want to slow down this holiday season if they want to stay healthy, Japanese researchers reported at this year's American Heart Association Scientific Sessions in Anaheim, California. 

The more traumatic events a woman experiences during her lifetime, the more likely she is to become obese, researchers reported at the American Heart Association’s Scientific Sessions this week.

People with high triglycerides, even in the presence of controlled low-density lipoprotein cholesterol (LDL-C), remain at increased risk for major adverse cardiac events (MACE) and incur higher healthcare costs, according to a retrospective data analysis presented Nov. 12 at the American Heart Association scientific sessions in Anaheim, California.

Lifestyle modification (LSM) and medication can prevent people at risk of diabetes from developing the condition in the short term, but only LSM is associated with a sustained risk reduction, according to a meta-analysis published Nov. 6 in JAMA Internal Medicine.

 

Recent Headlines

'Sitting is the new smoking': Sedentary behavior linked to increased all-cause mortality

For years, medical professionals and media personalities alike have warned against sitting for prolonged periods, coining the phrase "sitting is the new smoking" to describe the health risks of a sedentary lifestyle. But how much is too much?

Scientists link obstructive sleep apnea, cardiometabolic dysfunction

A group of Johns Hopkins scientists have uncovered a link between sleep apnea and cardiometabolic dysfunction that could help explain heart disease in sleep patients, according to a recent study.

Type 2 diabetes medicine cuts risk of CV death independent of background blood sugar control

Empagliflozin tablets reduced the risk of cardiovascular death by 38 percent in people with type 2 diabetes and established cardiovascular disease (CVD), according to a randomized, placebo-controlled trial of more than 7,000 patients. And new analyses demonstrate a similar benefit was seen in all patients, regardless of blood sugar levels at baseline or after the introduction of background treatment.

Research links socioeconomic stress to metabolic syndrome in black youth

Socioeconomic stress could have a major impact on black young adults’ heart health, according to a new study published in the Journal of the American Heart Association.

Metabolically healthy obese individuals still at increased risk for heart disease

After spending nearly six years researching the relationship between metabolically healthy obesity and risk of cardiovascular disease, a team of U.K. doctors are suggesting that even “healthy” obese individuals are more prone to develop heart issues.

Children exposed to toxic dust after 9/11 show signs of heart disease

Children exposed to toxic dust after the attack on New York's World Trade Centers in 2001 are showing early signs of cardiovascular risks, a study suggests.

'Good' cholesterol not so great in extreme cases

Apparently, it’s possible to have too much of a good thing. At least that’s what researchers are suggesting about high-density lipoprotein (HDL) cholesterol, widely known as the “good” type of cholesterol.

Diabetes drug gains FDA indication for CV benefit

The diabetes drug liraglutide (Victoza) secured an indication from the FDA to reduce the risk of major adverse cardiovascular (CV) events in adults with Type 2 diabetes and established cardiovascular disease, Novo Nordisk announced Aug. 25.

Statin therapy ineffective in patients with advanced kidney disease

Patients with advanced renal dysfunction received no significant benefit from statin therapy following acute MI in a study of 861 individuals.

Study finds similar cost value of CAC testing, widespread statin treatment

When it comes to choosing whether to initiate statin treatment, similar clinical and economic consequences result if clinicians follow current guidelines or use coronary artery calcium (CAC) testing to guide that decision, according to new research.

Pages